Mucinous adenocarcinoma
MONDO:0004957An invasive adenocarcinoma composed of malignant glandular cells which contain intracytoplasmic mucin. Often, the infiltrating glandular structures are associated with mucoid stromal formation. It may arise from the large and small intestine, appendix, stomach, lung, ovary, breast, corpus uteri, cervix, vagina, and salivary gland.
Also known as: adenocarcinoma, mucinous, malignant, colloid adenocarcinoma, colloid carcinoma, gelatinous adenocarcinoma, gelatinous carcinoma, mucin-producing adenocarcinoma (morphologic abnormality), mucinous adenocarcinoma, mucinous carcinoma
2803 clinical trials for this condition and its sub-types, 18 tagged with Mucinous adenocarcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Mucinous adenocarcinoma
-
Colon mucinous adenocarcinoma 2 trials · 21 incl. sub-types
1 sub-type
- Mucinous adenocarcinoma of the appendix 4 trials · 19 incl. sub-types Sub-types →
-
Ovarian mucinous adenocarcinoma 11 trials · 14 incl. sub-types
1 sub-type
- Ovarian mucinous cystadenocarcinoma 4 trials
-
Mucinous cystadenocarcinoma 1 trial · 5 incl. sub-types
4 sub-types
- Ovarian mucinous cystadenocarcinoma 4 trials
- Appendix mucinous cystadenocarcinoma 0 trials
- Breast mucinous cystadenocarcinoma 0 trials
- Pancreatic mucinous cystadenocarcinoma 0 trials Sub-types →
-
Endometrial mucinous adenocarcinoma 2 trials
-
Mucoepidermoid carcinoma 2 trials
12 sub-types
- Cutaneous mucoepidermoid carcinoma 0 trials
- Extrahepatic bile duct mucoepidermoid carcinoma 0 trials
- Lacrimal gland mucoepidermoid carcinoma 0 trials
- Laryngeal mucoepidermoid carcinoma 0 trials
- Mucoepidermoid breast carcinoma 0 trials
- Mucoepidermoid esophageal carcinoma 0 trials
- Oral cavity mucoepidermoid carcinoma 0 trials Sub-types →
- Paranasal sinus mucoepidermoid carcinoma 0 trials
- Pulmonary mucoepidermoid carcinoma 0 trials Sub-types →
- Thymic mucoepidermoid carcinoma 0 trials
- Thyroid gland mucoepidermoid carcinoma 0 trials
- Trachea mucoepidermoid carcinoma 0 trials
-
Breast mucinous carcinoma 1 trial
1 sub-type
-
Rectum mucinous adenocarcinoma 1 trial
1 sub-type
- Anal mucinous adenocarcinoma 0 trials
-
Cervical mucinous adenocarcinoma 0 trials · 1 incl. sub-types
6 sub-types
- Endocervical type cervical mucinous adenocarcinoma 1 trial
- Cervical mucinous adenocarcinoma, minimal deviation variant 0 trials
- Cervical villoglandular adenocarcinoma 0 trials
- Intestinal variant cervical mucinous adenocarcinoma 0 trials
- Signet ring cell variant cervical mucinous adenocarcinoma 0 trials
- Uterine ligament mucinous adenocarcinoma 0 trials
-
Colloid carcinoma of the pancreas 0 trials
-
3 sub-types
-
Gallbladder mucinous adenocarcinoma 0 trials
-
Lung colloid adenocarcinoma 0 trials
2 sub-types
-
Mucinous gastric adenocarcinoma 0 trials
-
Mucinous pancreas adenocarcinoma 0 trials
Most studied deeper sub-types
-
Can a new immunotherapy combo tame aggressive appendiceal cancer?
Disease control Not yet recruitingThis phase II trial is testing whether combining the experimental immunotherapy drug ivonescimab with chemotherapy (paclitaxel) delivered directly into the abdomen can safely and effectively treat people with high-grade metastatic appendiceal adenocarcinoma that cannot be removed…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
New drug combo aims to tackle deadly pancreatic cancer
Disease control Not yet recruitingThis study tests a new drug called samuraciclib added to standard chemotherapy for people with a specific type of advanced pancreatic cancer (basal-like). The goal is to find the safest dose and see if the combination helps shrink tumors or slow the cancer. About 67 adults with n…
Phase 1/2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC